Literature DB >> 6684019

[Treatment of idiopathic thrombocytopenic purpura in adults with high-dosage immunoglobulins].

F W Busch, P Ostendorf, M Schnaidt, P Wernet, H D Waller.   

Abstract

Four of five patients with idiopathic thrombocytopenic purpura (ITP) responded to high-dose immunoglobulin treatment with transitory rise in platelet count to normal values, while the fifth had only minimal improvement. In the individual case there was good correlation between serum-IgG concentration and platelet count, but an influence on platelet-associated IgG could not be demonstrated with certainty. Treatment with high-dose IgG is apparently particularly suitable for patients with ITP refractory to steroids or splenectomy, in whom bleeding complications or operative procedures make a transitory rise in platelet count desirable.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6684019     DOI: 10.1055/s-2008-1069736

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  2 in total

1.  Dose-response relationship in the treatment of idiopathic thrombocytopenic purpura with intravenous immunoglobulin.

Authors:  B Emmerich; E Hiller; F Woitinas; P A Maubach; H Riess; C Nerl; R G Geursen
Journal:  Klin Wochenschr       Date:  1987-04-15

2.  High-dose intravenous IgG for chronic idiopathic thrombocytopenic purpura in adults.

Authors:  J M Lang; A Faradji; C Giron; J P Bergerat; F Oberling
Journal:  Blut       Date:  1984-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.